Loading...
UnitedHealthcare Community Plan evidence-based clinical guideline for adult spine imaging applicable only to Ohio members; defines appropriate use of advanced imaging modalities, documentation requirements, modality selection, and coding/billing considerations. This is Part 1 (preface and general guidance) of a multi-part guideline, effective Nov 1, 2025.
Annual evidence-based updates reflected in version v1.0.2025 with effective date November 1, 2025.
This document is Part 1 of 6 of the UnitedHealthcare Community Plan Adult Spine Imaging Guidelines (Policy CSRAD014OH.D) and applies only to the state of Ohio. It is version V1.0.2025 with an effective date of November 1, 2025. The guideline series represents UnitedHealthcare proprietary, evidence-based clinical guidance for advanced imaging and related procedures and the coverage stance for this part is mixed (coverage with specific criteria and investigational exclusions). Key actionable requirements include documenting a recent in-person clinical evaluation and a documented 6‑week trial of provider‑directed conservative therapy (with clinical re-evaluation) prior to most advanced imaging unless a listed Red Flag Indication applies, and including required supporting documentation (history, focused neurologic exam, prior imaging/x-rays when required) when submitting requests or seeking authorization.
Application and Evidence Standards
This section applies to Ohio and describes document-level applicability and the evidence standards used to develop these spine imaging guidelines.
General Imaging Modality Guidance
Guidance for selection and use of imaging modalities, contrast administration, and rules for repeat imaging.
3D Rendering (CPT 76376, 76377) Criteria
Criteria for 3D rendering (CPT 76376, 76377) including clinical scenarios and billing constraints.
ANY of the following
Imaging Guidance Codes (CT/MR/US-guided procedures)
Rules for image-guided procedures and reporting of guidance codes.
Prerequisites for Advanced Diagnostic Imaging
Prerequisites that must all be met before advanced diagnostic imaging of the spine is supported.
ALL of the following
Red Flag Indications
Red flag indications that warrant expedited imaging. ANY of the following life- or limb-threatening conditions support immediate advanced imaging with the modality indicated.
ANY of the following
Spinal Infection Imaging (excerpt)
Spinal infection imaging considerations (excerpt).
Severe Radicular Pain
Criteria for imaging in severe radicular pain.
Radiculopathy definition (SP-1.3)
Definition of radiculopathy used in the guideline.
MRI of the Spine Indications (SP-2.2)
Indications for MRI of the spine.
CT of the Spine Indications (SP-2.3)
Indications for CT of the spine.
CT/Myelography Indications (SP-2.4)
Indications for CT myelography.
Post-lumbar Discography CT (SP-2.5)
Indications and constraints for post-lumbar discography with CT.
MR Spectroscopy and Positional MRI
Guidance regarding MR spectroscopy and positional MRI.
Ultrasound of the Spinal Canal (SP-2.6)
Ultrasound use in spinal canal and paraspinal evaluation.
Limitations in Degenerative Disorders (SP-2.7)
Limitations of imaging in degenerative disorders.
MR Spectroscopy and Positional MRI
Guidance on miscellaneous spinal lesions and less common modalities.
Neck (Cervical Spine) Pain without and with Neurological Features (SP-3.1)
Neck (Cervical Spine) pain criteria for imaging without and with neurological features, including stenosis and trauma.
ANY of the following
ANY of the following
Medical-Necessity Criteria (Spine Imaging)
Upper back (thoracic spine) pain criteria for imaging without and with neurological features, including stenosis and trauma.
ANY of the following
ANY of the following
Neck/Thoracic/Lumbar Condition-specific Sections (SP-3 to SP-6)
Condition-specific prerequisites and imaging choices for neck, thoracic, lumbar, coccydynia, lower extremity radicular pain and trauma sections.
High-risk factors listed in policy section.
Definitions of radiculopathy per SP-1.3.
Ankylosing spondylitis/DISH exceptions noted.
Myelopathy, Spondylolysis/Spondylolisthesis, Lumbar Stenosis
Myelopathy, spondylolysis/spondylolisthesis, and lumbar spinal stenosis imaging logic and exceptions.
Repeat imaging not necessary for established non-union without healing potential.
SI Joint Pain, Inflammatory Spondylitis, Fibromyalgia
SI joint, inflammatory spondylitis, and fibromyalgia coverage stances and indications.
Compression Fractures, Cancer-related Pain, Syringomyelia, Spinal Deformities
When imaging is indicated for compression fractures, cancer-related spinal pain, syringomyelia, and spinal deformities.
Postoperative/Pre-op/Interventional Imaging Requirements and Timing
Postoperative imaging, preoperative timing thresholds, and imaging requirements prior to injections, SCS, and post-augmentation.
Use nuclear medicine when MRI/CT nondiagnostic for suspected failed fusion.
Nuclear Medicine — Indications (SP-17)
Nuclear medicine indications including SPECT/SPECT-CT, bone scan and when nuclear imaging is preferred/allowed.
Appropriate follow-up timeframe depends on disease and prior imaging.
| 72148 | Magnetic resonance (e.g., proton) imaging, spinal canal and contents, cervical; without contrast material |
| 72149 | Magnetic resonance (e.g., proton) imaging, spinal canal and contents, cervical; with contrast material(s) |
| 72150 | Magnetic resonance (e.g., proton) imaging, spinal canal and contents, cervical; without and with contrast material(s) |
| 72156 | Magnetic resonance (e.g., proton) imaging, spinal canal and contents, thoracic; without contrast material |
| 72157 | Magnetic resonance (e.g., proton) imaging, spinal canal and contents, thoracic; with contrast material(s) |
| 72158 | Magnetic resonance (e.g., proton) imaging, spinal canal and contents, thoracic; without and with contrast material(s) |
| 72195 | Magnetic resonance (e.g., proton) imaging, spinal canal and contents, lumbar; without contrast material |
| 72196 | Magnetic resonance (e.g., proton) imaging, spinal canal and contents, lumbar; with contrast material(s) |
| 72197 | Magnetic resonance (e.g., proton) imaging, spinal canal and contents, lumbar; without and with contrast material(s) |
| 72192 | Magnetic resonance, any site of spine, without contrast, including T1, T2, multisequence; cervical, thoracic, or lumbar (alternate code referenced in source) |
| 76499 | Unlisted radiology procedure (used for quantitative MR analysis when no specific code applies) |
| 76390 | Magnetic resonance guidance for needle placement (when applicable to quantitative analysis workflow) |
| 76390-XS | Example modifier pairing when spectroscopy not covered (placeholder) |
| 77058 | MR spectroscopy (not covered per guideline) - example coding note |
| 76498 | Unlisted magnetic resonance procedure (use for whole-body MRI or other unlisted MR procedures when appropriately documented) |
| 76499 | Unlisted radiology procedure (CT/MR) |
| 78813 | Positron emission tomography (PET) with concurrently acquired CT for attenuation correction and anatomic localization; single area or whole body |
| 76498 | Unlisted magnetic resonance procedure (used to report whole-body MRI when applicable) |
| 77012 | Fluoroscopic guidance for percutaneous procedures (example guidance code) |
| 76942 | Ultrasound guidance for vascular access (example) |
| -26 | Professional component |
| -TC | Technical component |
| 72191 | MR pelvis or sacrum (included when relevant to SI joint imaging) |
In-person clinical evaluation required
Initial in-person clinical evaluation must be performed prior to requesting advanced imaging for the current episode. The in-person exam must include a relevant history and a detailed neurologic examination (manual muscle testing, dermatomal sensory distribution, reflex testing, and nerve root tension signs). Telehealth/telephone/email does not satisfy the in-person requirement for an initial evaluation. Document recency when indicated by specific sections.
Document conservative therapy trial
Document that the patient underwent a provider-directed conservative therapy trial and a subsequent clinical re-evaluation prior to advanced imaging unless a Red Flag Indication is present. The required conservative trial is six weeks and the clinical re-evaluation documenting failure of significant clinical improvement must be recent (within the prior 12 weeks). Exceptions apply for Red Flag Indications where immediate advanced imaging is indicated.
Prior authorization may be required for 3D rendering (76376/76377)
Prior authorization may be required for CPT 76376 and 76377 (3D rendering) even when the underlying imaging/procedure does not require prior authorization. When using these codes, document the physician's concurrent supervision/participation as required by the codes. Note: plans may request PA for the 3D codes even if the index procedure does not need PA.
Document active physician participation for 3D post-processing
For CPT 76376/76377, document active physician participation (concurrent supervision) in the 3D post-processing. The documentation should describe the physician's role and monitoring during reconstruction and the specific elements determined by the physician.
Guidance codes: one unit per encounter and pairing rules
Guidance/interventional imaging codes are limited to one unit per encounter and have specific pairing rules. Do not bill a diagnostic CT/MRI in the same session as an imaging guidance code when the guidance code includes the necessary imaging. 77021 is not appropriate for MRI-guided breast biopsy; use biopsy codes instead.
Quantitative MR analysis investigational / NMN
Quantitative multiparametric MR analysis and volumetric/quantitative brain MRI analysis are considered investigational or not medically necessary. Expect potential denials for these Category III and related codes.
Plain x-rays and imaging recency requirements for prior auth
Plain radiographs and other imaging recency requirements apply for prior authorization in specific scenarios. Ensure required x-rays or imaging studies are performed within the policy-specified windows and include documentation. There are special look-back and timing rules for injections, pre-op imaging, and post-procedure CT.
Document rationale for bone scan/SPECT/SPECT-CT
Document the clinical rationale when selecting bone scan/SPECT/SPECT-CT for nuclear medicine evaluation. Typical indications include implant loosening, nondiagnostic MRI/CT for suspected failed fusion, osteomyelitis, spondylolysis, and occult fractures.
Background: These are UnitedHealthcare proprietary, evidence‑based clinical guidelines that evaluate advanced imaging and procedures across modalities (nuclear medicine, ultrasound, CT, MRI, PET, radiation oncology and selected procedural imaging). They are intended to guide appropriate imaging selection, support Choosing Wisely initiatives, and are reviewed annually. This Part 1 contains preface and general guidance and specifically applies to adult spine imaging for Ohio members (Part 1 of 6; effective November 1, 2025; Version V1.0.2025).
| Evidence Source | Takeaway |
|---|---|
| FDA Gadolinium Retention (FDA 2018) | Recommend limiting GBCA use to situations where contrast yields necessary additional information; assess repetitive GBCA use |
| ACR Practice Parameters / Appropriateness Criteria (MRI/CT/US/PET) | Provide modality-specific performance standards and support MRI/CT after failed conservative care; referenced throughout spine indications |
| Conservative care outcome (multiple studies/meta-analyses) | Most acute neck/back pain improves after ~6 weeks of provider-directed conservative therapy; imaging before this often not beneficial and linked to higher intervention rates |
| Risk of early MRI / imaging overuse studies | Early MRI associated with increased rates of surgery (e.g., reported eightfold increase); imaging can lead to downstream interventions without improved outcomes |
| Nuclear Medicine / SPECT indications (SP-17) and evidence | SPECT/CT and bone scan supported for radiographically occult spondylolysis, implant loosening, failed fusion workup, and occult fractures when MRI/CT nondiagnostic—not for routine initial LBP |
| 3D Rendering CPT 76376/76377 guidance | 3D post-processing codes require documented active physician participation; not for 2D reformatting and may need prior authorization |
| CT/MR/US Guidance Procedure Codes (77012,77021,77013,76942,19085 etc.) | Guidance codes include imaging needed for procedures; bill appropriately (one unit per encounter) and avoid billing diagnostic codes concurrently |
| Billing restrictions for 3D rendering and guidance codes | Do not report 3D rendering with certain studies (CAD/MRA/CTA/SPECT/PET/etc.) and avoid duplicate billing (e.g., 70486 with 77011) |
Concurrent supervision (3D rendering): active physician participation and monitoring of the 3D reconstruction process (design of anatomic region, tissue types/structures displayed, images archived, monitoring/adjustment) is required to bill CPT 76376/76377; document supervision or participation.
Standard imaging: plain film, CT, MRI, or ultrasound typically used for initial and subsequent evaluations.
Radiculopathy: for the purpose of this policy, pain in a specified dermatomal distribution causing significant functional limitation plus one or more objective neurologic findings (e.g., motor weakness, sensory change, reflex asymmetry) or concordant imaging/EMG evidence.
Radiculitis: radicular pain without objective neurological findings.
Red Flag Indications (SP‑1.2): clinical features that obviate the requirement for a conservative trial (examples include motor weakness, cauda equina, infection, fracture, cancer, severe radicular pain, aortic aneurysm/dissection).
DISH: diffuse idiopathic skeletal hyperostosis.
Advanced diagnostic imaging studies: imaging such as MRI, CT, CT/myelography, and SPECT/CT as referenced in the Spine Imaging Guidelines.
Annual evidence-based update (policy history note)
Interim evidence-based update (policy history note)
Annual evidence-based update (policy history note)
Current part contains v1.0.2025 content; effective date November 1, 2025
Red flag considerations may supersede timing.